Development of new approaches to sterility testing of heterologous serum products by membrane filtration method

Reliable evaluation of blood products sterility is a very important and one of the most complex and critical control methods in the context of microbiological safety. The membrane filtration method that uses a closed-circuit system has, for many years, been the main and the most preferable sterility test method for all known medicinal products. However, Russian manufacturers perform sterility testing of heterologous serum products by direct inoculation method only. The present study was aimed at exploring the feasibility of performing sterility testing of heterologous serum products by membrane filtration. It was shown that sample preparation could be modified by dilution of samples to, on average, 1.5-2 times the initial volume with a sterile 0.9 % sodium chloride solution followed by membrane filtration at a geared-up rate which lowers protein sorption by the membrane filter. The study helped to determine the range of protein impact on the membrane when testing serum products according to the State Pharmacopoeia 13th ed. It was shown that various types of filter elements from mixed cellulose esters and Durapore^® (PVDF) could be used to test serum products by membrane filtration with a protein impact range of up to 12 g of protein per membrane. The results of heterologous serum products sterility testing by direct inoculation method and by membrane filtration were found to be comparable. Adaptation of the procedure to protein-containing products makes it possible to perform sterility testing by a more reliable and modern method. The authors can recommend the incorporation of the above-cited test procedure into quality standards for products concerned together with the currently used direct inoculation method.

микробиологическая безопасность, лекарственные средства, гетерологичные сывороточные препараты, стерильность, мембранная фильтрация, оценка качества, microbiological safety, drugs, heterologous serum products, sterility, membrane filtration, quality assessment

1. ÎÔÑ. 1.2.4.0003.15. Sterility. State Pharmacopoeia of the Russian Federation, 13th ed. V. 3. Available from: http://www.femb.ru/feml (in Russian).

2. The International Pharmacopoeia (First and Second Supl.) 4th ed. 2011. Available from: http://apps.who.int/phint/en/p/about.

3. European Pharmacopoeia 9.0; 2017: 20601. Available from: http://online6.edqm.eu/ep900.

4. Indian Pharmacopoeia, 2.2.11/6.0/2012.

5. Japanese Pharmacopoeia, 4.06/XVI/2012.

6. USP, the US Pharmacopeia, 35//2012.

7. Balashenko SG, Urban VP. Immune globulins in veterinary. Minsk. 1972 (in Russian).

8. Neslin RS. Structure and biosynthesis of antibodies. Moscow. 1972 (in Russian).

9. ФС. 3.3.1.0041.15. Antigangrenous serum polyvalent horse. State Pharmacopoeia of the Russian Federation, 13th ed. V. 3. Available from: http://www.femb.ru/feml (in Russian).

10. ФС. 3.3.1.0042.15. Anti-butulinic serum types A, B, E horse. State Pharmacopoeia of the Russian Federation, 13th ed. V. 3. Available from: http://www.femb.ru/feml (in Russian).

11. ФС. 3.3.1.0043.15. Serum antidiphtheria horse. State Pharmacopoeia of the Russian Federation, 13th ed. V. 3. Available from: http://www.femb.ru/feml (in Russian).

12. ФС. 3.3.1.0044.15. Anti-tetanus horse serum. State Pharmacopoeia of the Russian Federation, 13th ed. V. 3. Available from: http://www.femb.ru/feml (in Russian).

13. ФС. 3.3.1.0045.15 Serum against venom of viper ordinary horse. State Pharmacopoeia of the Russian Federation, 13th ed. V. 3. Available from: http://www.femb.ru/feml (in Russian).

14. ФС. 3.3.1.0046.15 Serum horse, diluted 1:100. State Pharmacopoeia of the Russian Federation, 13th ed. V. 3. Available from: http://www.femb.ru/feml (in Russian).

15. Movsesyants ÀÀ, Bondarev VP, Olefir YuV, Merkulov VÀ, Shimchuk LF. Quality standards for immunobiological medicinal products — new texts in the State Pharmacopoeia of the Russian Federation. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2016; (2): 38–41 (in Russian).

16. Serum horse purified diluted 1:100, FSUE «NPO «Microgen» MH RF, Russia, LS-000349-010212, amendments No. 1, 2, 3 (in Russian).

17. Anti-butulinic serum type A horse purified concentrated liquid, FSUE «NPO «Microgen» MH RF, Russia, LS-001212 – 220711, amendments No. 1, 2, 3 (in Russian).

18. Anti-butulinic serum type B horse purified concentrated liquid, FSUE «NPO «Microgen» MH RF, Russia LS-001213 – 270711, Rev. 1, 2, 3 (in Russian).

19. Anti-butulinic serum type E horse purified concentrated liquid, FSUE «NPO «Microgen» MH RF, Russia LS-001214 – 220711, amendments No. 1, 2, 3 (in Russian).

20. Antigangrenous serum horse purified concentrated liquid, FSUE «NPO «Microgen» MH RF, Russia LS-001035 – 301211, amendments No. 1, 2, 3, 4 (in Russian).

21. Serum antidiphtheria horse purified concentrated liquid, FSUE «NPO «Microgen» MH RF, Russia LS-001409 – 211211, amendments No. 1, 2, 3 (in Russian).

22. Anti-tetanus serum horse purified concentrated liquid, FSUE «NPO «Microgen» MH RF, Russia LS-000058 – 200911, amendments No. 1, 2, 3, 4 (in Russian).

23. Serum against venom of viper ordinary horse purified concentrated liquid (Antitoxin venom of viper ordinary), FSUE «NPO «Microgen» MH RF, Russia R N002482/01-010212, amendment No. 1 (in Russian).

24. Order of the Ministry of health of the Russian Federation of 28 October 2015 ¹ 770 «About modification of the order of Ministry of health of the Russian Federation from November 21, 2014 No. 768 «On approval of General Pharmacopeia articles and Pharmacopeia articles» (in Russian).

25. Sukhanova SM, Berdnikova ZE, Zacharova NE. A new approach to testing drugs for sterility. In: All-Russia Scientific-practical. conf. «Vaccinology-2010». Perfection of immunobiological means of prevention, diagnosis and treatment of infectious diseases. Moscow; 2010. P. 108 (in Russian).

26. System for controlling the sterility of medicinal products Steritest. Available from: https://goo.gl/5ZRQN8 (in Russian).